Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Cortellini A, Cannita K, Tiseo M, Cortinovis DL, Aerts JGJV, Baldessari C, Giusti R, Ferrara MG, D'Argento E, Grossi F, Guida A, Berardi R, Morabito A, Genova C, Antonuzzo L, Mazzoni F, De Toma A, Signorelli D, Gelibter A, Targato G, Rastelli F, Chiari R, Rocco D, Gori S, De Tursi M, Mansueto G, Zoratto F, Filetti M, Bracarda S, Citarella F, Russano M, Cantini L, Nigro O, Buti S, Minuti G, Landi L, Ricciardi S, Migliorino MR, Natalizio S, Simona C, De Filippis M, Metro G, Adamo V, Russo A, Spinelli GP, Di Maio M, Banna GL, Friedlaender A, Addeo A, Pinato DJ, Ficorella C, Porzio G. Cortellini A, et al. Among authors: friedlaender a. Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12. Eur J Cancer. 2021. PMID: 33721704 Free article.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Buti S, Bersanelli M, Perrone F, Bracarda S, Di Maio M, Giusti R, Nigro O, Cortinovis DL, Aerts JGJV, Guaitoli G, Barbieri F, Ferrara MG, Bria E, Grossi F, Bareggi C, Berardi R, Torniai M, Cantini L, Sforza V, Genova C, Chiari R, Rocco D, Della Gravara L, Gori S, De Tursi M, Di Marino P, Mansueto G, Zoratto F, Filetti M, Citarella F, Russano M, Mazzoni F, Garassino MC, De Toma A, Signorelli D, Gelibter A, Siringo M, Follador A, Bisonni R, Tuzi A, Minuti G, Landi L, Ricciardi S, Migliorino MR, Tabbò F, Olmetto E, Metro G, Adamo V, Russo A, Spinelli GP, Banna GL, Addeo A, Friedlaender A, Cannita K, Porzio G, Ficorella C, Carmisciano L, Pinato DJ, Mazzaschi G, Tiseo M, Cortellini A. Buti S, et al. Among authors: friedlaender a. Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3. Eur J Cancer. 2021. PMID: 33934059 Free article.
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials.
Trillo Aliaga P, Trapani D, Sandoval JL, Crimini E, Antonarelli G, Vivanet G, Morganti S, Corti C, Tarantino P, Friedlaender A, Belli C, Minchella I, Locatelli M, Esposito A, Criscitiello C, Curigliano G. Trillo Aliaga P, et al. Among authors: friedlaender a. Cancers (Basel). 2021 Nov 20;13(22):5829. doi: 10.3390/cancers13225829. Cancers (Basel). 2021. PMID: 34830983 Free PMC article.
Neoadjuvant Immunotherapy: A Promising New Standard of Care.
Boydell E, Sandoval JL, Michielin O, Obeid M, Addeo A, Friedlaender A. Boydell E, et al. Among authors: friedlaender a. Int J Mol Sci. 2023 Jul 24;24(14):11849. doi: 10.3390/ijms241411849. Int J Mol Sci. 2023. PMID: 37511609 Free PMC article. Review.
Novel targets for immune-checkpoint inhibition in cancer.
Borgeaud M, Sandoval J, Obeid M, Banna G, Michielin O, Addeo A, Friedlaender A. Borgeaud M, et al. Among authors: friedlaender a. Cancer Treat Rev. 2023 Nov;120:102614. doi: 10.1016/j.ctrv.2023.102614. Epub 2023 Aug 12. Cancer Treat Rev. 2023. PMID: 37603905 Free article. Review.
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Bordry N, Addeo A, Jaksic C, Dutoit V, Roux-Lombard P, Shah DP, Shah PK, Gayet-Ageron A, Friedlaender A, Bugeia S, Gutknecht G, Battagin A, Di Marco M, Simand PF, Labidi-Galy I, Fertani S, Sandoval J, Dietrich PY, Mach N. Bordry N, et al. Among authors: friedlaender a. iScience. 2021 Dec 24;25(1):103699. doi: 10.1016/j.isci.2021.103699. eCollection 2022 Jan 21. iScience. 2021. PMID: 34977496 Free PMC article.
222 results